MSN and ductal breast carcinoma in situ: We analyzed the p-Moesin expression levels in 55 samples, including 34 BrCas (8 ductal breast carcinoma in situ and 26 invasive ductal breast carcinoma), 2 benign breast disease, 13 lymph nodes and 6 adjacent normal tissues by IHC staining assays.